Carey O Connor Kolaja Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

Carey O Connor Kolaja is Director of Revance Therapeutics, Inc.. Currently has a direct ownership of 31,561 shares of RVNC, which is worth approximately $81,111. The most recent transaction as insider was on May 01, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.6K
0% 3M change
90.57% 12M change
Total Value Held $81,111

Carey OConnor Kolaja Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 32.22%
31,561 Common Stock
Jun 15 2023
SELL
Open market or private sale
$70,600 $28.24 p/Share
2,500 Reduced 13.12%
16,561 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
$45,300 $18.12 p/Share
2,500 Added 11.6%
19,061 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
3,534 Added 17.59%
16,561 Common Stock
May 04 2022
BUY
Grant, award, or other acquisition
-
6,059 Added 31.75%
13,027 Common Stock
May 05 2021
BUY
Grant, award, or other acquisition
-
674 Added 8.82%
6,968 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
6,294 Added 50.0%
6,294 Common Stock
COK

Carey O Connor Kolaja

Director
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC